|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07H 19/10 | |
| C07H 19/20 | |||
| C07H 19/06 | |||
| C07H 19/12 | |||
| C07H 19/23 | |||
| A61K 31/7076 | |||
| A61P 9/00 |
| (11) | Patento numeris | 3512860 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17849975.2 |
| Europos patento paraiškos padavimo data | 2017-09-18 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-07-24 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-11-25 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/CA2017/051095 |
| Data | 2017-09-18 |
| (87) | Numeris | WO 2018/049534 |
| Data | 2018-03-22 |
| (30) | Numeris | Data | Šalis |
| 201662395401 P | 2016-09-16 | US | |
| 201662395411 P | 2016-09-16 | US | |
| 201662395430 P | 2016-09-16 | US |
| (72) |
GUINDON, Yvan, CA
MOCHIRIAN, Philippe, CA
NEMER, Mona, CA
|
| (73) |
LCB Pharma Inc.,
12230 Avenue Lemesurier, Montréal, Québec H4K 2B3,
CA
Université D`Ottawa, 800 King Edward, 3042 VRTT, Ottawa, Ontario K1N 6N5, CA |
| (54) | NUCLEOSIDE AND NUCLEOTIDE ANALOGUES BEARING A QUATERNARY ALL-CARBON STEREOGENIC CENTER AT THE 2` POSITION AND METHODS OF USE AS A CARDIOPROTECTIVE AGENT |
| NUCLEOSIDE AND NUCLEOTIDE ANALOGUES BEARING A QUATERNARY ALL-CARBON STEREOGENIC CENTER AT THE 2` POSITION AND METHODS OF USE AS A CARDIOPROTECTIVE AGENT |